TFA in research peptides: where trifluoroacetate comes from, what a salt form is, and how to find it on a certificate of analysis

Why TFA is in the vial: solid-phase synthesis and cleavage#

Synthetic peptides are built one residue at a time on an insoluble polymer bead, the method for which Bruce Merrifield received the 1984 Nobel Prize in Chemistry: the first amino acid is anchored to the resin, each new one is coupled to the growing chain, excess reagents are washed away, and the finished peptide is released only when the sequence is complete.^[1] In the Fmoc/tBu strategy most synthesis houses use, reactive side chains (arginine, lysine, histidine, aspartate, glutamate, serine, threonine, tyrosine, cysteine, tryptophan) are protected throughout by acid-labile groups. The final step, cleavage, removes all of those groups and cuts the peptide from the resin at once, and the reagent that does both is concentrated trifluoroacetic acid, typically 90–95% TFA with small amounts of scavengers such as triisopropylsilane, water or ethanedithiol.^[2]

The crude peptide is precipitated, usually in cold ether, and dried. It already contains TFA, because the acid protonates every basic site and the trifluoroacetate anion pairs with each positive charge. TFA replaced the far more hazardous hydrogen fluoride of the earlier Boc chemistry; the trade-off is that the product is a trifluoroacetate salt before anyone has tried to purify it.^[2][5]

TFA in reversed-phase HPLC purification#

The crude material is purified by reversed-phase HPLC, and the mobile phase almost always contains about 0.1% TFA. The acid sets a low pH, which sharpens peaks, and the trifluoroacetate anion pairs with the peptide's positive charges, which changes how strongly the peptide is held on the hydrophobic column and helps separate it from closely related impurities. Wang and Carr, studying anionic additives in reversed-phase chromatography of peptides and basic drugs, describe TFA as both the routine acidic modifier and an ion-pairing agent that contributes to retention.^[3][4]

When the purified fractions are pooled and freeze-dried, the acetonitrile and water leave and the TFA paired with the peptide stays. The powder in the vial is therefore a trifluoroacetate salt twice over, from cleavage and from purification, with the TFA either bound to basic residues or adsorbed in the lyophilizate as a contaminant.^[4]

What a TFA salt is: counter-ions and basic residues#

A peptide in acidic solution is a cation. Its N-terminal amine and the side chains of lysine, arginine and histidine each carry a positive charge, and neutrality requires an anion for every one of them. In a TFA salt that anion is trifluoroacetate (CF3COO−); in an acetate salt it is acetate (CH3COO−); in a hydrochloride it is chloride (Cl−). The peptide sequence is identical in all three. What differs is the mass and chemistry of the passenger ions.^[4]

The expected number of counter-ions is set by the number of basic sites. Erckes and colleagues at ETH Zurich tested this in a 2025 study: for synthetic peptides carrying two to nine positive charges, the TFA count measured after exchange with dilute hydrochloric acid settled at or slightly below the number of charges, while the freshly purified peptides carried more TFA than their charge predicted. The excess was unbound acid trapped in the powder, which repeated lyophilization removed.^[5] A TFA-salt peptide therefore carries at least one trifluoroacetate per basic residue plus a variable amount of free TFA.

How much of the mass is counter-ion: TFA content versus HPLC purity#

This is where the chemistry meets the label. HPLC purity is a ratio of peak areas: the main peptide peak as a percentage of all peptide-related peaks the detector sees. It describes the peptide population, not the powder. Water, counter-ions and inorganic salts are not counted, so a lot can be 99% pure by HPLC and still be only 70–80% peptide by weight. The fraction of the gross mass that is actually peptide is the net peptide content, and the counter-ion is usually the largest reason it falls short of 100%. Our guide to comparing research peptide prices per milligram covers the pricing consequences; the point here is the measurement.

The numbers are not small. Trifluoroacetic acid has a molecular weight of about 114; acetic acid is about 60 and hydrogen chloride about 36.5, and each basic residue adds one of these. Erckes and colleagues calculated theoretical TFA mass fractions of roughly 22–35% for their cationic peptides as TFA salts, against about 8–17% as chlorides, and measured TFA contents up to 35% of total weight before exchange.^[5] A 2002 Thermo Fisher ion-chromatography application note found that commercial peptides sold as TFA salts contained about 193–202 mg of TFA per gram, acetate-salt peptides 80–100 mg of acetate per gram, a crude synthetic peptide 19.6% TFA by dry weight, and that peptides sold with no counter-ion specified contained TFA.^[6] The table shows the arithmetic for a hypothetical 1,000-dalton peptide with three basic sites; the figures are illustrative. A label mass means the salt unless the listing says otherwise, and if the counter-ion is not quantified the real peptide quantity is unknown even when purity is reported to two decimal places.^[5]

Acetate and hydrochloride: salt exchange#

Because TFA is unwanted in material destined for biological work, suppliers offer counter-ion exchange, usually to acetate or hydrochloride. The classic method dissolves the TFA salt in dilute hydrochloric acid and lyophilizes, repeated several times, so the TFA is displaced and carried off with the water vapor. Sikora and colleagues note that traces of TFA typically remain, that efficiency reaches up to about 98% after several repetitions, that only acids stronger than TFA work (acetic acid alone is too weak), and that concentrated HCl can hydrolyze the peptide.^[4] The 2025 ETH study addressed the lack of consensus on conditions (published methods range from 2 to 100 mM HCl, repeated one to five times) and found 10 mM HCl optimal: TFA fell below the quantification limit of all three of their methods after a single treatment with no loss of HPLC purity, though acid stability can depend on sequence.^[5]

Acetate salts are usually made by running the purification or a final polishing step with acetic acid or ammonium acetate in place of TFA, or by passing the peptide over an anion-exchange resin loaded with acetate.^[4] Acetate has largely replaced TFA as the counter-ion in peptide drug substances, and the pharmacopoeias treat acetate itself as an impurity whose level must be measured.^[4][9] Hydrochloride has the lowest mass of the three and is the form Cornish and colleagues recommended for biological testing.^[7]

Why TFA matters for in-vitro assays#

Trifluoroacetate is not biologically inert. In 1999 Cornish and colleagues, working with fetal rat osteoblast cultures, found that TFA on its own at 10−8 to 10−7 M reduced cell number and thymidine incorporation within 24 hours; similar effects appeared in articular chondrocyte cultures and neonatal mouse calvariae. When the same group compared trifluoroacetate and hydrochloride salts of amylin, amylin-(1-8) and calcitonin in osteoblasts, the TFA salts consistently suppressed proliferation more. The authors warned that TFA could mask a real proliferative effect of a peptide or falsely suggest an antiproliferative one, and recommended converting peptides to a hydrochloride or an equivalent salt before testing them in biological systems.^[7]

The effects are not limited to proliferation. Tipps, Iyer and Mihic reported in 2012 that trifluoroacetate at 100 µM to 3 mM enhanced glycine-evoked currents at α1 and α1β glycine receptors expressed in Xenopus oocytes, with no effect on GABA-A or 5-HT3A receptors in the same system, and described TFA contamination of HPLC-purified peptides as a source of experimental variability that requires control, because the amount a peptide carries is unknown and varies from batch to batch.^[8] A 2025 review in Biomolecules collects further primary examples: in a 1990 study TFA stimulated proliferation and protein synthesis in C6 glioma cells; Pini and colleagues reported in 2012 that the TFA salt of the antimicrobial peptide M33 was 5–30% more cytotoxic to normal bronchial epithelial cells than the acetate; and Boullerne and colleagues found in 2014 that a TFA-containing MOG peptide brought forward the onset of experimental autoimmune encephalomyelitis in animals by about five days compared with the acetate.^[9]

Counter-ions also change the peptide physically. Johansson and colleagues found that trifluoroacetate, sulfate and bicarbonate induced helical structure in LL-37 whereas chloride did least; the Erckes study found one cell-penetrating peptide, pVEC, crossed liposome membranes only as its TFA salt; and TFA absorbs strongly near 1,700 cm−1, overlapping the amide I band, while in electrospray mass spectrometry it suppresses the peptide signal.^[4][5][9]

Recognizing the salt form on a certificate of analysis#

A certificate of analysis can state the salt form in several places, and often does so in none of them. Our guide to reading a certificate of analysis covers the purity and identity sections; the table below covers the lines that speak to counter-ion and content.

Counter-ion content is measured by its own methods, separate from the HPLC-UV run that gives purity. Ion chromatography with suppressed conductivity detection is the technique of first choice; the 2002 Thermo Fisher note reached detection limits of 10–300 ng/mL from a 10 µL sample, and the United States Pharmacopeia has since published a dedicated procedural chapter, <503.1> Trifluoroacetic Acid (TFA) in Peptides, alongside <503> for acetic acid.^[4][6][10] Fluorine-19 NMR identifies trifluoroacetate by a singlet near −75 ppm and was validated as a quantitative method in the 2025 ETH study, which also validated a mixed-mode HPLC-ELSD method that detects TFA, chloride and sodium in one run and found infrared spectroscopy suitable only for qualitative confirmation.^[4][5] A report that states a TFA or acetate percentage without naming a method is asserting a value, not showing one.

What a laboratory should ask a supplier#

1. Which salt form is this lot: trifluoroacetate, acetate or hydrochloride? If "not specified", treat it as TFA.
2. Has the counter-ion content been measured for this lot, by what method (ion chromatography, 19F NMR, HPLC-ELSD), and what was the value?
3. If the material is described as acetate or hydrochloride, what is the residual TFA after exchange?
4. What is the net peptide content, and how was it derived? A gross mass with no water and counter-ion figures leaves the peptide quantity unknown.
5. Does the stated molecular weight refer to the free peptide or to the salt?
6. For cell-based work: is the same lot available as a hydrochloride or acetate, or with a counter-ion blank, so the vehicle control matches the sample?

Renuvia's lots are tested by Freedom Diagnostics Testing for HPLC-UV purity and LC-MS identity, with a measured content reported alongside, and each lot's report is published in the COA library; lots whose report has not yet been issued are shown as pending. The purity and identity sections are explained in HPLC and mass spectrometry explained. A laboratory that needs the counter-ion identity or content for a specific lot, or a particular salt form for an assay, should ask before ordering.